Raymond W. Klecker - Concepedia

Concepedia

Author

Raymond W. Klecker

National Cancer Institute

Also Known As

R W Klecker, Raymond Klecker, Raymond W Klecker, Raymond W. Klecker, Raymond W. Klecker Jr., Raymond. W. Klecker

44

Publications

2.8K

Citations

24

H-Index

72

Concepts

All Affiliations

National Cancer Institute United States Food and Drug Administration Center for Drug Evaluation and Research National Institutes of Health Wayne State University

RW

About

Raymond W. Klecker is an author at National Cancer Institute specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	21	1.8K
2	Biochemistry	10	10	817
3	Health Sciences	7	7	594
4	Natural Sciences	5	5	353
5	Engineering	2	2	261

Raymond W. Klecker

×

33

Publications

2.8K

Citations

24

H-Index

	Year	Citations
Reversal of Adriamycin Resistance by Verapamil in Human Ovarian Cancer Alfred M. Rogan, Thomas C. Hamilton, Robert C. Young, Science MedicinePharmacologyGynecologyPharmacotherapyAdriamycin Resistance	1984	399
Plasma and cerebrospinal fluid pharmacokinetics of 3′-azido-3′-deoxythymidine: A Novel pyrimidine analog with potential application for the treatment of patients with AIDS and related diseases Raymond W. Klecker, Jerry M. Collins, Robert Yarchoan, Clinical Pharmacology & Therapeutics	1987	381
Oxidative destruction of erythrocyte ghost membranes catalyzed by the doxorubicin-iron complex Charles E. Myers, Luca Gianni, Charles B. Simone, Biochemistry EngineeringIron MetabolismAltmetric Attention ScoreDoxorubicin-iron ComplexChemical Biology	1982	240
Portal levels and hepatic clearance of 5-fluorouracil after intraperitoneal administration in humans. James L. Speyer, Paul H. Sugarbaker, Jerry M. Collins, PubMed Intraperitoneal AdministrationSurgical OncologyGastrointestinal PharmacologyGastroenterologyPathology	1981	220
Clinical Pharmacokinetics of Suramin in Patients With HTLV‐III/LAV Infection Jerry M. Collins, Raymond W. Klecker, Robert Yarchoan, The Journal of Clinical Pharmacology	1986	138
Synthesis of 2′-deoxy-2′-[18F]fluoro-β-D-arabinofuranosyl nucleosides, [18F]FAU, [18F]FMAU, [18F]FBAU and [18F]FIAU, as potential PET agents for imaging cellular proliferation Thomas J. Mangner, Raymond W. Klecker, Lawrence W. Anderson, Nuclear Medicine and Biology BiochemistryPotential Pet AgentsNatural SciencesCellular ProliferationMolecular Biology	2003	109
Pharmacological evaluation of intravenous delivery of 5-bromodeoxyuridine to patients with brain tumors. Angelo Russo, Luca Gianni, Timothy J. Kinsella, PubMed PharmacotherapyHigh-grade GliomasGliomaNeuro-oncologyIntravenous Delivery	1984	108
Glucuronidation of 3′-Azido-3′-Deoxythymidine (Zidovudine) by Human Liver Microsomes: Relevance to Clinical Pharmacokinetic Interactions with Atovaquone, Fluconazole, Methadone, and Valproic Acid Carol Braun Trapnell, Raymond W. Klecker, Carlos Jamis‐Dow, Antimicrobial Agents and Chemotherapy ImmunologyClinical Pharmacokinetic InteractionsPharmacotherapyAntiviral DrugMedicinal Chemistry	1998	106
Adriamycin accumulation and metabolism in adriamycin-sensitive and -resistant human ovarian cancer cell lines Karen G. Louie, Thomas C. Hamilton, Margaret A. Winker, Biochemical Pharmacology OncologyMedicineGynecologyAdriamycin AccumulationCancer Biology	1986	99
Pharmacokinetics of 2‘,3’‐Dideoxycytidine in Patients with AIDS and Related Disorders Raymond W. Klecker, Jerry M. Collins, Robert Yarchoan, The Journal of Clinical Pharmacology	1988	98

Page 1